Intrinsic value of Mayne Pharma Group Limited (MYX)
Live fair value data for Mayne Pharma Group Limited (MYX) is currently unavailable. Please check again shortly.
Current Price: $444.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Mayne Pharma Group Limited (MYX) undervalued or overvalued?
Based on the current model output, Mayne Pharma Group Limited appears to be undervalued with a upside of 62.00%.
Fair value vs market price — Mayne Pharma Group Limited (MYX)
Unlock premium access to view the live fair value comparison against current market price for MYX.
Frequently Asked Questions - MYX
How is MYX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for MYX.
Is MYX undervalued or overvalued right now?
MYX is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for MYX: open their intrinsic value pages.